Similarly, CD44+/CD24− CSCs were present at low frequency in TUBO tumours and slightly increased in BALB-neuT tumours, while they were abundant in both 4T1 and TS/A tumours (Fig. 3e), in agreement with the results obtained in vitro. This evidence concerns the gene CD44 and neoplasm.